Cannabis Legalization News Podcast

Latest Episodes:

Cannabis Legalization News Updates for October 2023 Oct 22, 2023

Show notes

New research from the Federal Reserve Bank finds that states with legal marijuana see a significant economic boost, but also experience an increase in social costs. The report found that states that legalized marijuana for adults saw moderate economic gains after the policy change was implemented, with the number of jobs directly in the marijuana industry growing from less than 125,000 to more than 425,000 between 2017 and 2022. However, the report also found that states with legal marijuana saw an increase in social costs, including substance use disorders, chronic homelessness, and arrests.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

The Latest Federal Cannabis Legalization Updates | Tom & Miggy on the Road Oct 15, 2023

Show notes

Send us Fan Mail

Cannabis News for October 15 2023 | Tom & Miggy on the Road This week Tom & Miggy are on the road and cover new federal workplace guidelines for THC testing do not create any new laws. Rather, they clarify that medical marijuana use is not a protected activity under federal law, and that employers are still able to fire employees for testing positive for THC, even if they have a medical marijuana card.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Cannabis Legalization News for October 2023 Oct 08, 2023

Show notes

Send us Fan Mail

Cannabis Legalization News for October 2023 The House of Representative had quite the shake-up this week leaving many to wonder how that will impact cannabis policy with the recent proposal by the HHS to reschedule cannabis and efforts to pass the SAFER Banking Act. Currently, marijuana is federally illegal, but legal in some states for medical and/or recreational use. This creates a problem for marijuana businesses, which have difficulty accessing banking services. Federal law prohibits banks from doing business with businesses that are involved in illegal activities. There is bipartisan support for legislation that would allow marijuana businesses to access banking services, but it has not yet been passed. Some Republicans have expressed opposition to the legislation, arguing that it would give legitimacy to an illegal industry. If a new House Speaker is elected who is more supportive of marijuana reform, it could increase the chances of legislation passing that would allow marijuana businesses to access banking services. This would be a major win for the marijuana industry and would make it easier for businesses to operate and grow. a lawsuit that has been filed against the US Department of Health and Human Services (HHS) to compel the release of a letter that the Biden administration sent to the Drug Enforcement Administration (DEA) recommending that marijuana be rescheduled. The letter has not been released publicly, but it is believed to contain the Biden administration's reasoning for why marijuana should be rescheduled and what the DEA should do next. The lawsuit was filed by attorney Matthew Zorn, who argues that the letter is a public record and that HHS is required to release it. The lawsuit also claims that HHS is withholding the letter in order to delay or prevent the DEA from rescheduling marijuana. The DEA currently classifies marijuana as a Schedule I drug, which means that it has a high potential for abuse and no currently accepted medical use. Rescheduling marijuana would make it easier for researchers to study the plant and for patients to access it for medical purposes. The outcome of the lawsuit is uncertain, but it could have a significant impact on the future of marijuana reform in the United States. If the court orders HHS to release the letter, it could put pressure on the DEA to reschedule marijuana. This week we also have news out of Arizona, Illinois, Ohio, New York, and Michigan. We also have guest Matt White joining us. Matt white is the creator behind the Strain Show, the Youtube channel where you can learn everything you ever wanted to know about cannabis. Don't miss this latest episode of Cannabis Legalization News. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabisindustry #cannabislegalization

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

The SAFER Act in the Senate | Easy DOT Physicals Dr.Nuesse Oct 01, 2023

Show notes

Send us Fan Mail

The SAFER Act in the Senate | Easy DOT Physicals Dr.Nuesse The Senate Banking Committee voted 14-9 on Wednesday to advance the Secure and Fair Enforcement Regulation (SAFER) Banking Act. This is the first time that a Senate committee has approved a marijuana banking bill, and it is a significant step forward for the cannabis industry. The SAFER Banking Act would allow banks to work with state-legal cannabis businesses without fear of federal penalties. This would provide a number of benefits to the cannabis industry, including: Reduced risk of crime and violence: Cannabis businesses would be able to use banks to deposit and withdraw money, which would reduce the need to keep large amounts of cash on hand. This would make them less of a target for criminals. Increased access to capital: Cannabis businesses would be able to apply for loans and lines of credit from banks, which would help them to grow and expand their operations. Reduced costs: Cannabis businesses would no longer have to pay high fees to use money services businesses (MSBs) to process their financial transactions. The passage of the SAFER Banking Act by the Senate Banking Committee is a positive sign for the cannabis industry. However, it is important to note that the bill still needs to be passed by the full Senate and House of Representatives before it can become law. It is also unclear when the bill will be considered by the full Senate. In the meantime, cannabis businesses will continue to face challenges in accessing banking services. However, the passage of the SAFER Banking Act by the Senate Banking Committee is a sign that progress is being made towards addressing this issue. This week we have guest speaker Dr. Matthew Nuesse joining us. Dr. Nuesse is a Certified Medical Examiner with nearly a decade of experience in drug testing and pre-employment medical examinations. He runs the largest YouTube channel specifically focused on federal drug testing. He co-founded the drug testing education course Exploroacademy.com. We have an all new Name That Strain and other titillating news stories from the week on Cannabis Legalization News. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #medicinalcannabis

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Federal Cannabis Legalization News Sep 24, 2023

Show notes

Send us Fan Mail

Federal Cannabis Legalization News | Safter Banking Act Update This week we saw a major push by Senate Majority Leader Chuck Schumer to legalize cannabis at the federal level when he circulated a petition, asking for signatures from supporters. These types of email campaigns are often used to build up their own email lists for political fundraising; however, Schumer has been an outspoken proponent of allowing banks to do business in the cannabis industry. On Wednesday, Schumer and a bipartisan group of cannabis supporters introduced a revised version of the SAFE Banking Act called the SAFER Banking Act. This updated version has some new provisions and is set for mark-up in the Senate next week. Meanwhile, two republican supporters of the SAFER Banking Act introduced their own bill to impede the proposition of rescheduling cannabis to a less regulated class. The DEA Act, as it’s known, would require congressional approval to propose a change to any federal drug law, adding another hurdle to the prospect of cannabis legalization if it were to pass both chambers of Congress. The MORE Act was also refiled again this week, making its way to the House for a third time. The bill is solely sponsored by Democrats and faces an uphill battle to make it through while the House is under GOP majority. New York continues to make headlines for their calamitous roll out of the adult-use industry in the state. Leafly, Ron DeSantis, and the NCAA also get some of the spotlight this week. Tune in to hear all about it. This is Cannabis Legalization News for the week of September 18th. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabis #cannabislegalization

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Cannabis Rescheduling News From The Feds! Legalization News Sep 17, 2023

Show notes

Send us Fan Mail

Federal rescheduling of cannabis has been a big topic in recent news. A government analysis predicts the DEA is likely to reschedule cannabis. The analysis, conducted by the Congressional Research Service (CRS), is based on the DEA's past practices and the HHS's recent recommendation to reschedule marijuana. The CRS analysis states that the DEA has historically been reluctant to reschedule marijuana, but that it has also shown a willingness to do so when there is strong scientific evidence to support the change. In this case, the HHS's recommendation is based on a comprehensive review of the scientific literature, which found that there is sufficient evidence to support the medical use of marijuana. The CRS analysis also notes that the DEA is currently facing a number of challenges, including budget cuts and increasing public pressure to reform its drug scheduling system. These factors could make the DEA more likely to reschedule marijuana, as it would be a way to show that the agency is responsive to public concerns. However, it is important to note that the CRS analysis is just a prediction. The DEA is not required to follow the HHS's recommendation, and it could ultimately decide to keep marijuana in Schedule I. The DEA is expected to make a decision on the scheduling of marijuana in the coming months. If the DEA does decide to reschedule marijuana, it would be a major victory for advocates of cannabis reform. It would make it easier for researchers to study the potential medical benefits of marijuana, and it would make it easier for doctors to prescribe marijuana to patients with certain conditions. It would also make it possible for banks to offer services to marijuana businesses, which would help to legitimize the industry. Here are some of the specific implications of rescheduling marijuana to Schedule III: •It would make it easier for researchers to study the potential medical benefits of marijuana. •It would make it easier for doctors to prescribe marijuana to patients with certain conditions. •It would make it possible for banks to offer services to marijuana businesses. •It would make it easier for people who use marijuana to obtain housing and employment. •It would have limited implications for state recreational marijuana programs and those who use marijuana recreationally. The decision of whether or not to reschedule marijuana is a complex one, and there are a number of factors that the DEA will need to consider. However, the HHS's recommendation is a significant step forward and could pave the way for further reforms in the future. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Federal Court Legalized Delta-8 THC & More Sep 10, 2023

Show notes

Send us Fan Mail

Has a federal court legalized delta-8 THC with a recent federal court order that temporarily blocked the DEA from enforcing a rule that would have classified delta-8 THC as a controlled substance? The order was issued by a U.S. District Court judge in Washington, D.C., and it is still in effect. However, it is important to note that this is just a temporary order, and it is not yet clear whether the DEA will appeal the decision. If the DEA does appeal the decision, it is possible that the court could ultimately rule that delta-8 THC is a controlled substance. In that case, delta-8 THC would be illegal in all 50 states. Even if the DEA does not appeal the decision, it is still possible that some states could ban delta-8 THC. As of now, only 14 states have banned delta-8 THC, but other states could follow suit. So, the legal status of delta-8 THC is still uncertain. It is possible that it could be legal in all 50 states, but it is also possible that it could be illegal in some or all states. It is important to stay up-to-date on the latest developments in this area. Here are some additional things to keep in mind: The 2018 Farm Bill legalized hemp, which is defined as cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis. Delta-8 THC is a compound that occurs naturally in hemp, but it can also be produced synthetically. The DEA issued a rule in 2020 that would have classified delta-8 THC as a controlled substance. However, the rule was challenged in court, and the federal court order that I mentioned earlier blocked the DEA from enforcing the rule. The legal status of delta-8 THC is still evolving, and it is important to stay up-to-date on the latest developments.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

What Does Schedule III Cannabis Mean for the Industry? Sep 03, 2023

Show notes

Send us Fan Mail

The U.S. Department of Health and Human Services (HHS) recently recommended that cannabis be rescheduled from Schedule I to Schedule III under the federal Controlled Substances Act (CSA). Schedule I controlled substances are considered to have no currently accepted medical use and a high potential for abuse. Schedule III controlled substances are considered to have a moderate to low potential for abuse and a currently accepted medical use. The HHS recommendation is based on a scientific and medical review of cannabis that was conducted by the Food and Drug Administration (FDA). The FDA review found that there is "substantial evidence" that cannabis and cannabis-derived products are effective in treating certain medical conditions, such as chronic pain, nausea and vomiting associated with chemotherapy, and spasticity associated with multiple sclerosis. The HHS recommendation is non-binding, and the final decision on whether to reschedule cannabis will be made by the Drug Enforcement Administration (DEA). The DEA is expected to take several months to review the HHS recommendation and make a decision. If the DEA does reschedule cannabis to Schedule III, it would be a significant step forward for the cannabis industry. It would make it easier for researchers to study cannabis and for doctors to prescribe it to patients. It would also make it easier for businesses to sell and distribute cannabis products. However, even if the DEA reschedules cannabis to Schedule III, it would still be illegal to possess, distribute, or manufacture cannabis under federal law. The only way to make cannabis legal under federal law would be for Congress to pass a law specifically legalizing it. The HHS recommendation is a positive development for the cannabis industry, but it is important to remember that it is just a recommendation. The DEA has the final say on whether to reschedule cannabis, and it is possible that the DEA will decide to keep cannabis in Schedule I. Only time will tell what the DEA will decide. However, the HHS recommendation is a significant step forward, and it is a sign that the federal government is slowly starting to come to terms with the reality of cannabis. Here are some of the potential benefits of rescheduling cannabis to Schedule III: It would make it easier for researchers to study cannabis and for doctors to prescribe it to patients. It would make it easier for businesses to sell and distribute cannabis products. It could reduce the number of people who are incarcerated for cannabis-related offenses. It could generate tax revenue for the government.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Cannabis News - August 27, 2023 - Legalization News Podcast Aug 27, 2023

Show notes

Send us Fan Mail

#Cannabis #Legalization #News is a professional and informative podcast that serves as the ultimate source for all the latest news and updates on the cannabis industry. Hosted by Tom & Miggy; the show aims to empower listeners by providing accurate and up-to-date information about cannabis legalization. The podcast explores a wide range of topics, including industry trends, regulatory changes, financial protection for cannabis businesses, social equity, workplace policies, and the balance between regulation and personal freedom. With expert analysis and thought-provoking discussions, Cannabis Legalization News is a go-to resource for licensed operators and enthusiasts seeking valuable insights into the ever-evolving landscape of cannabis legislation. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) Cannabis Legalization News is committed to keeping its audience informed and engaged, making it an invaluable resource for staying up-to-date with the latest developments in the cannabis industry. Please note that the views expressed in the podcast are for informational purposes only and should not be considered legal advice. Listeners are advised to consult with qualified professionals before making any decisions regarding cannabis use or legal matters.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

DEA Says No to Delta-8 Aug 20, 2023

Show notes

Send us Fan Mail

The DEA has recently confirmed that it believes delta-8 THC synthesized from CBD is federally illegal. This is based on a 2021 letter from DEA's Drug & Chemical Evaluation Section Chief Terrence Boos. Boos states, “Arriving at delta-8-THC by a chemical reaction starting from CBD makes the delta-8-THC synthetic and therefore, not exempted by the Agriculture Improvement Act. Any quantity of delta-8-THC obtained by chemical means is a controlled substance.” Hemp itself is considered a legal agricultural product under the 2018 Farm Bill. The DEA's position is based on the Controlled Substances Act (CSA), which defines a "synthetic drug" as "a drug that is not naturally occurring and that is chemically made." The DEA argues that delta-8 THC is not naturally occurring in hemp, and that it is therefore a synthetic drug. The DEA's position is controversial, and there is some legal debate about whether it is correct. However, the DEA has the authority to enforce the CSA, and it is likely that they will continue to pursue cases against businesses that sell delta-8 THC synthesized from CBD.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu